<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

Destination
Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing

Amneal Pharmaceuticals taps GLP-1 growth via a Pfizer-linked manufacturing deal, gaining exposure without clinical risks while scaling injectables and peptides. [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
How to use Apple Invites to plan your next event

Apple's Invites app is a simple way to throw together an event invitation directly from your iPhone or web browser. The app is free to download from the App Store, and technically you don't [...]

Match Score: 50.85

Destination
Is AMRX Stock Undervalued? Sales Multiple, Target, Upside

Amneal Pharmaceuticals trades below peers on sales multiple despite strong gains, with a $14 target hinging on execution, mix shift, and margin strength. [...]

Match Score: 33.03

Destination
AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook

Amneal Pharmaceuticals heads into 2026 with diversified growth drivers, rising margins and a faster launch cadence supporting steady revenue expansion. [...]

Match Score: 33.03

Destination
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally. Three U.S. sen [...]

Match Score: 27.95

Destination
Weight Watchers files for bankruptcy amid refocus on GLP-1 drugs

WeightWatchers (WW) announced Tuesday that it is filing for bankruptcy in an attempt to crawl out of more than $1 billion in debt. The news comes as the company is amid a refocus on prescribing weight [...]

Match Score: 27.95

venturebeat
Bright Machines says its new hybrid robot cell could help solve a major AI infrastructure bottleneck

Bright Machines wants to solve one of the least glamorous but most consequential problems in the AI buildout: what happens to quality data when a human being has to touch the production line.The San F [...]

Match Score: 27.73

Destination
Intel's next-gen manufacturing process is reportedly still struggling

Intel is reportedly still struggling with a chipmaking process crucial to its future. Reuters reports that the company's 18A process is still producing low yields and high defect rates. Intel has [...]

Match Score: 26.90

Destination
OpenAI's recent chip deals heap more pressure on TSMC

In recent weeks, OpenAI has signed blockbuster deals with AMD and Broadcom to build vast numbers of AI chips. Much of the focus has been on the financial implications, since OpenAI will need hundreds [...]

Match Score: 26.03

venturebeat
Kai-Fu Lee's brutal assessment: America is already losing the AI hardware war to China

China is on track to dominate consumer artificial intelligence applications and robotics manufacturing within years, but the United States will maintain its substantial lead in enterprise AI adoption [...]

Match Score: 24.74